Search results
Results from the WOW.Com Content Network
Dysgraphia is a hard disorder to detect as it does not affect specific ages, gender, or intelligence. [13] The main concern in trying to detect dysgraphia is that people hide their disability behind their verbal fluency/comprehension and strong syntax coding as a means to mask the handwriting impairments caused by the disorder. [13]
Unlike Rey, Osterrieth was primarily interested in the measure as an assessment of whether or not children had developed the concept of a holistic or gestalt principle by various ages, as manifested by the way they approached the figure drawing. Based on his experimentation, Osterrieth recognized several important trends.
Dyscravia [1] is a voicing substitution dysgraphia, i.e. a type of writing disorder in which the affected person confuses letters denoting sounds that differ in their voicing attribute (e.g. writing "dap" instead of "tap" or "tash" instead of "dash").
The Strengths and Difficulties Questionnaire (SDQ) is a screening questionnaire for emotional and behavioral problems in children and adolescents ages 2 through 17 years old, developed by child psychiatrist Robert N. Goodman in the United Kingdom.
LBLD consists of dyscalculia which comprises the reading of numbers sequentially, learning the time table, and telling time; [6] dyslexia; and difficulties associated with written language such as trouble learning new vocabulary, letters and alphabets.
The Institute of Education Sciences (the independent, non-partisan statistics, research, and evaluation arm of the U.S. Department of Education), describes the approach as follows: "Orton-Gillingham is a broad, multisensory approach to teaching reading and spelling that can be modified for individual or group instruction at all reading levels.
Phonological dyslexia is a reading disability that is a form of alexia (acquired dyslexia), [1] resulting from brain injury, stroke, or progressive illness and that affects previously acquired reading abilities.
Based on the results of a 2019 Cochrane meta-analysis of available studies the Mini-ACE should only be used as an adjunct to a full clinical assessment and not alone for the screening of dementia or mild cognitive impairment in patients presenting with or at risk for cognitive decline. [14]